Hamard, Marie
Durand, Claire
Deconinck, Laurène
Hobson, Claire Amaris
Lescure, François-Xavier
Yazdanpanah, Yazdan
Peiffer-Smadja, Nathan
Raynaud-Simon, Agathe
Funding for this research was provided by:
Gérond’if
Article History
Received: 1 May 2024
Accepted: 15 October 2024
First Online: 27 November 2024
Declarations
:
: The study protocol was approved by the Ethics Committee of <i>Gérond’if</i>, <i>gérontopole d’Ile de France</i>. It followed the framework of the “Reference Methodology” (MR-004) related to the processing of personal data in the context of research not involving the human person (Deliberation No. 2018 − 155 of 3 May 2018).
: Written and oral consent were obtained from participants prior to each interview.
: Gérond’if (le gérontopole d’Ile de France) did not contributed to the design, collection of data, analysis, supervision of the study or the writing of the manuscript.
: Marie Hamard received funding from Gérond’if (le gérontopole d’Ile de France) to carry out this work. Laurene Deconinck received support for attending meetings and/or travel from Tillotts Pharma. The other authors have no conflicts of interest to declare.